News

StockStory.org on MSN1d
5 Revealing Analyst Questions From Myriad Genetics’s Q1 Earnings Call
Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns ...
Business Insider5mon
Myriad Genetics announces hereditary cancer risk assessment study published
Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing. The ...
Nasdaq6mon
Myriad Genetics' MyRisk® Hereditary Cancer Test with RiskScore® Recognized as Top Advance in Genomic Medicine - Nasdaq
Myriad Genetics, Inc. announced that its MyRisk® Hereditary Cancer Test with RiskScore® was recognized in the American Journal of Human Genetics as one of the top 10 significant advances in ...
Nasdaq5mon
Myriad Genetics Study Shows Increased Completion Rates for Hereditary Cancer Testing Through Online Screening and Education Tools - Nasdaq
Myriad Genetics, Inc. announced a study indicating that the use of its online screening tool, MyGeneHistory®, alongside a virtual education program, significantly increased the completion rates ...
Morningstar2y
Myriad Genetics Invests in Growth Opportunities; Shares Appear Slightly Overvalued - Morningstar
Myriad Genetics started out as the monopoly in hereditary breast cancer diagnostics. Its oldest test was BRACAnalysis, a predictive test for mutations tied to an increased risk of hereditary ...
Morningstar1y
Myriad Genetics Invests for Growth Across Core Testing Offering, Payer Dynamics Remain Challenging - Morningstar
Myriad Genetics started out as the monopoly in hereditary breast cancer diagnostics. Its oldest test was BRACAnalysis, a predictive test for mutations tied to an increased risk of hereditary ...
Business Insider4mon
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools - Markets Insider
SALT LAKE CITY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a collaboration with Gabbi ...
Hosted on MSN8mon
Myriad Genetics Shares Fall Despite Partnership With jscreen - MSN
Myriad Genetics, Inc. MYGN has announced a strategic partnership with jscreen, a national organization focused on genetic education and preventative testing for high-risk populations. This ...
Seeking Alpha8y
Myriad Genetics: Buy On The Drop? - Seeking Alpha
Myriad Genetics reported fourth quarter earnings after the close on Tuesday. The stock is down 22% after-hours on poor Q1 2017 and FY2017 guidance.
Seeking Alpha6y
Myriad Genetics - Diversification Going Strong, Priced In Already
Myriad Genetics has delivered on its diversification promise, thanks to savvy deals, creating real diversification from its core hereditary cancer test franchise. I like the progress being made ...
The Motley Fool5y
Here's Why Myriad Genetics Shares Got Crushed Today
The genetic-testing leader just whacked its fiscal full-year 2020 guidance. Not so for Myriad Genetics. A change in billing codes commonly used for its hereditary cancer tests, originally expected ...